Back to today’s briefing

Story perspectives

GSK's New CEO Confident Despite £35 Billion Skepticism

2/5/2026

44 7 Full Breakdown

Summary

Story summary

Luke Miels, the new CEO of GSK, presented 2025 results and expressed confidence in the strategy despite analysts' skepticism that a £35 billion target is more realistic.
Miels, with GSK since 2017, emphasizes "scientific courage" and agility as essential in the pharmaceutical sector.
Former CEO Emma Walmsley is credited with the demerger of the consumer goods division and a focus on R&D, aiming for over £40 billion in revenue by 2031.

1 of 1

Story summary

Luke Miels, the new CEO of GSK, presented 2025 results and expressed confidence in the strategy despite analysts' skepticism that a £35 billion target is more realistic.
Miels, with GSK since 2017, emphasizes "scientific courage" and agility as essential in the pharmaceutical sector.
Former CEO Emma Walmsley is credited with the demerger of the consumer goods division and a focus on R&D, aiming for over £40 billion in revenue by 2031.